Abstract |
The present experiments examined the ability of the novel 5-HT1A receptor antagonist to block responses mediated by postsynaptic and presynaptic 5-HT1A receptors in vivo. Pretreatment with p-MPPI reduced or blocked the effect of the 5-HT1A receptor agonist 8-OH-DPAT on two responses mediated by postsynaptic 5-HT1A receptors, reduction of body temperature and the 5-HT behavioral syndrome. Administration of p-MPPI alone did not alter body temperature or produce symptoms of the 5-HT syndrome. Pretreatment with p-MPPI also blocked the ability of 8-OH-DPAT to reduce extracellular 5-HT in the striatum, a response mediated by presynaptic 5-HT1A receptors in the dorsal raphe nucleus, but did not alter striatal 5-HT when administered alone. These results indicate that p-MPPI is an effective 5-HT1A receptor antagonist in vivo with no intrinsic activity. p-MPPI may prove to be a useful pharmacological tool for studying 5-HT1A receptors and their involvement in anxiety and affective disorders.
|
Authors | A R Allen, A Singh, Z P Zhuang, M P Kung, H F Kung, I Lucki |
Journal | Pharmacology, biochemistry, and behavior
(Pharmacol Biochem Behav)
1997 May-Jun
Vol. 57
Issue 1-2
Pg. 301-7
ISSN: 0091-3057 [Print] United States |
PMID | 9164586
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Aminopyridines
- Piperazines
- Serotonin Antagonists
- Serotonin Receptor Agonists
- 4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine
- Serotonin
- 8-Hydroxy-2-(di-n-propylamino)tetralin
|
Topics |
- 8-Hydroxy-2-(di-n-propylamino)tetralin
(pharmacology)
- Aminopyridines
(pharmacology)
- Animals
- Behavior, Animal
(drug effects)
- Body Temperature Regulation
(drug effects)
- Corpus Striatum
(drug effects, metabolism)
- Male
- Microdialysis
- Piperazines
(pharmacology)
- Presynaptic Terminals
(drug effects)
- Rats
- Rats, Sprague-Dawley
- Serotonin
(metabolism)
- Serotonin Antagonists
(pharmacology)
- Serotonin Receptor Agonists
(pharmacology)
|